{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Tulsa",
      "state": "OK",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65601",
      "recalling_firm": "Physicians Total Care, Inc.",
      "address_1": "12515 E 55th St Ste 100",
      "address_2": "N/A",
      "postal_code": "74146-6234",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "FAX",
      "distribution_pattern": "GA",
      "recall_number": "D-826-2013",
      "product_description": "Belladonna Alkaloids/PB (Belladonna Alkaloids / Phenobarbital) Tablets Phenobarbital USP 16.2 mg,  Hyoscyamine Sulfate 0.1037 mg,  Atropine Sulfate 0.0194 mg,  Scopolamine Hydrobromide 0.0065 mg  30-count bottle (NDC 54868-0031-04), Rx only, Repackaged and distributed by Physicians Total Care, Inc. Tulsa, OK 74146.",
      "product_quantity": "270 tablets",
      "reason_for_recall": "Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.",
      "recall_initiation_date": "20130617",
      "center_classification_date": "20130726",
      "termination_date": "20130815",
      "report_date": "20130807",
      "code_info": "Lot# 6GP2; Exp 10/14    West-Ward Lot /WWCN 67331A",
      "more_code_info": ""
    }
  ]
}